Following this, our dedicated care team takes care of insurance verification and prior authorization, ensuring semaglutide medication is covered under your plan
The US Food and Drug Administration (FDA) has approved the oral formulation of the GLP-1 weight-loss drug Wegovy, making it the first oral GLP-1 therapy cleared for obesity treatment ahead of rival Eli Lillys orforglipron, which is still under FDA review
van Hout B, Janssen MF, Feng YS, et al
Introduction to Tirzepatide In recent years, the landscape of type 2 diabetes management has evolved rapidly with the introduction of innovative therapies targeting both blood sugar control and associated complications like obesity
Male fertility studies show similar promise: a 10% weight reduction correlates with improved sperm concentration, motility, and morphology within 46 months